TVS Motor Company Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 7:51 am

Competitors of TVS Motor Company Ltd

All Competitor Stocks of TVS Motor Company Ltd

Quarterly Result

Last Updated: August 2, 2025, 1:05 am

Below is a detailed analysis of the quarterly data for TVS Motor Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 12,210.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,542.00 Cr. (Mar 2025) to 12,210.00 Cr., marking an increase of 668.00 Cr..
• For Expenses, as of Jun 2025, the value is 10,407.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,638.00 Cr. (Mar 2025) to 10,407.00 Cr., marking an increase of 769.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 1,803.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,904.00 Cr. (Mar 2025) to 1,803.00 Cr., marking a decrease of 101.00 Cr..
• For OPM %, as of Jun 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 15.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from -57.00 Cr. (Mar 2025) to 40.00 Cr., marking an increase of 97.00 Cr..
• For Interest, as of Jun 2025, the value is 551.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 551.00 Cr..
• For Depreciation, as of Jun 2025, the value is 315.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 292.00 Cr. (Mar 2025) to 315.00 Cr., marking an increase of 23.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 977.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,004.00 Cr. (Mar 2025) to 977.00 Cr., marking a decrease of 27.00 Cr..
• For Tax %, as of Jun 2025, the value is 34.00%. The value appears to be increasing, which may not be favorable. It has increased from 31.00% (Mar 2025) to 34.00%, marking an increase of 3.00%.
• For Net Profit, as of Jun 2025, the value is 643.00 Cr.. The value appears to be declining and may need further review. It has decreased from 698.00 Cr. (Mar 2025) to 643.00 Cr., marking a decrease of 55.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 12.84. The value appears to be declining and may need further review. It has decreased from 13.64 (Mar 2025) to 12.84, marking a decrease of 0.80.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:52 am

Growth

Last Updated: September 4, 2025, 9:40 pm

Balance Sheet

Last Updated: November 9, 2025, 1:31 pm

Below is a detailed analysis of the balance sheet data for TVS Motor Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 48.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 48.00 Cr..
• For Reserves, as of Sep 2025, the value is 8,068.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8,456.00 Cr. (Mar 2025) to 8,068.00 Cr., marking a decrease of 388.00 Cr..
• For Borrowings, as of Sep 2025, the value is 16,862.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 28,609.00 Cr. (Mar 2025) to 16,862.00 Cr., marking a decrease of 11,747.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 26,949.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10,539.00 Cr. (Mar 2025) to 26,949.00 Cr., marking an increase of 16,410.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 51,927.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 47,651.00 Cr. (Mar 2025) to 51,927.00 Cr., marking an increase of 4,276.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 9,147.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,644.00 Cr. (Mar 2025) to 9,147.00 Cr., marking an increase of 1,503.00 Cr..
• For CWIP, as of Sep 2025, the value is 701.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,465.00 Cr. (Mar 2025) to 701.00 Cr., marking a decrease of 764.00 Cr..
• For Investments, as of Sep 2025, the value is 1,316.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,247.00 Cr. (Mar 2025) to 1,316.00 Cr., marking an increase of 69.00 Cr..
• For Other Assets, as of Sep 2025, the value is 40,763.00 Cr.. The value appears strong and on an upward trend. It has increased from 37,294.00 Cr. (Mar 2025) to 40,763.00 Cr., marking an increase of 3,469.00 Cr..
• For Total Assets, as of Sep 2025, the value is 51,927.00 Cr.. The value appears strong and on an upward trend. It has increased from 47,651.00 Cr. (Mar 2025) to 51,927.00 Cr., marking an increase of 4,276.00 Cr..

However, the Borrowings (16,862.00 Cr.) are higher than the Reserves (8,068.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for TVS Motor Company Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 47.05. This value is within the healthy range. It has increased from 35.50 (Mar 24) to 47.05, marking an increase of 11.55.
• For Diluted EPS (Rs.), as of Mar 25, the value is 47.05. This value is within the healthy range. It has increased from 35.50 (Mar 24) to 47.05, marking an increase of 11.55.
• For Cash EPS (Rs.), as of Mar 25, the value is 73.66. This value is within the healthy range. It has increased from 58.87 (Mar 24) to 73.66, marking an increase of 14.79.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 178.98. It has increased from 142.78 (Mar 24) to 178.98, marking an increase of 36.20.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 178.98. It has increased from 142.78 (Mar 24) to 178.98, marking an increase of 36.20.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 927.99. It has increased from 823.93 (Mar 24) to 927.99, marking an increase of 104.06.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 141.41. This value is within the healthy range. It has increased from 118.91 (Mar 24) to 141.41, marking an increase of 22.50.
• For PBIT / Share (Rs.), as of Mar 25, the value is 119.40. This value is within the healthy range. It has increased from 98.38 (Mar 24) to 119.40, marking an increase of 21.02.
• For PBT / Share (Rs.), as of Mar 25, the value is 75.34. This value is within the healthy range. It has increased from 57.81 (Mar 24) to 75.34, marking an increase of 17.53.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 51.65. This value is within the healthy range. It has increased from 38.35 (Mar 24) to 51.65, marking an increase of 13.30.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 47.05. This value is within the healthy range. It has increased from 35.49 (Mar 24) to 47.05, marking an increase of 11.56.
• For PBDIT Margin (%), as of Mar 25, the value is 15.23. This value is within the healthy range. It has increased from 14.43 (Mar 24) to 15.23, marking an increase of 0.80.
• For PBIT Margin (%), as of Mar 25, the value is 12.86. This value is within the healthy range. It has increased from 11.94 (Mar 24) to 12.86, marking an increase of 0.92.
• For PBT Margin (%), as of Mar 25, the value is 8.11. This value is below the healthy minimum of 10. It has increased from 7.01 (Mar 24) to 8.11, marking an increase of 1.10.
• For Net Profit Margin (%), as of Mar 25, the value is 5.56. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 5.56, marking an increase of 0.91.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.07. This value is below the healthy minimum of 8. It has increased from 4.30 (Mar 24) to 5.07, marking an increase of 0.77.
• For Return on Networth / Equity (%), as of Mar 25, the value is 26.29. This value is within the healthy range. It has increased from 24.85 (Mar 24) to 26.29, marking an increase of 1.44.
• For Return on Capital Employeed (%), as of Mar 25, the value is 22.90. This value is within the healthy range. It has increased from 22.10 (Mar 24) to 22.90, marking an increase of 0.80.
• For Return On Assets (%), as of Mar 25, the value is 4.66. This value is below the healthy minimum of 5. It has increased from 3.99 (Mar 24) to 4.66, marking an increase of 0.67.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 1.64. This value exceeds the healthy maximum of 1. It has decreased from 1.86 (Mar 24) to 1.64, marking a decrease of 0.22.
• For Total Debt / Equity (X), as of Mar 25, the value is 3.25. This value exceeds the healthy maximum of 1. It has decreased from 3.73 (Mar 24) to 3.25, marking a decrease of 0.48.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.97. It has decreased from 1.01 (Mar 24) to 0.97, marking a decrease of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 1.5. It has increased from 1.02 (Mar 24) to 1.12, marking an increase of 0.10.
• For Quick Ratio (X), as of Mar 25, the value is 1.02. This value is within the healthy range. It has increased from 0.91 (Mar 24) to 1.02, marking an increase of 0.11.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 18.90. This value exceeds the healthy maximum of 8. It has increased from 18.77 (Mar 24) to 18.90, marking an increase of 0.13.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 21.25. This value is within the healthy range. It has decreased from 22.53 (Mar 24) to 21.25, marking a decrease of 1.28.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.47. This value is below the healthy minimum of 20. It has increased from 14.28 (Mar 24) to 14.47, marking an increase of 0.19.
• For Earning Retention Ratio (%), as of Mar 25, the value is 78.75. This value exceeds the healthy maximum of 70. It has increased from 77.47 (Mar 24) to 78.75, marking an increase of 1.28.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 85.53. This value exceeds the healthy maximum of 70. It has decreased from 85.72 (Mar 24) to 85.53, marking a decrease of 0.19.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.21. This value is within the healthy range. It has increased from 2.93 (Mar 24) to 3.21, marking an increase of 0.28.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.16. This value is below the healthy minimum of 3. It has increased from 1.95 (Mar 24) to 2.16, marking an increase of 0.21.
• For Enterprise Value (Cr.), as of Mar 25, the value is 139,163.99. It has increased from 125,803.88 (Mar 24) to 139,163.99, marking an increase of 13,360.11.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.16. This value exceeds the healthy maximum of 3. It has decreased from 3.21 (Mar 24) to 3.16, marking a decrease of 0.05.
• For EV / EBITDA (X), as of Mar 25, the value is 20.71. This value exceeds the healthy maximum of 15. It has decreased from 22.27 (Mar 24) to 20.71, marking a decrease of 1.56.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.61. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.61.
• For Retention Ratios (%), as of Mar 25, the value is 78.74. This value exceeds the healthy maximum of 70. It has increased from 77.46 (Mar 24) to 78.74, marking an increase of 1.28.
• For Price / BV (X), as of Mar 25, the value is 13.52. This value exceeds the healthy maximum of 3. It has decreased from 15.07 (Mar 24) to 13.52, marking a decrease of 1.55.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.61. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.61.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness